You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Addressing Patients at High Risk for SCA: Evaluating WEARIT-II

  • Authors: Niraj Varma, MD, PhD; Alon Barsheshet, MD; Valentina Kutyifa, MD, PhD
  • CME Released: 6/13/2016
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 6/13/2017
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, emergency medicine physicians, and critical care specialists.

The goal of this activity is to address the risk of sudden cardiac death (SCD) during the 90-day period following a cardiac event, as well as the management of patients and the utility of a wearable cardioverter defibrillator (WCD) during this period.

Upon completion of this activity, participants will be able to:

  1. Describe the management of patients in the 90-day period following a cardiac event and the risk of SCD during this time period
  2. Review guideline recommendations in managing patients at risk of SCD


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Niraj Varma, MD, PhD

    Staff, Cleveland Clinic, Cleveland, Ohio

    Disclosures

    Disclosure: Niraj Varma, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: BIOTRONIK; Medtronic, Inc.; Sorin Group; St. Jude Medical
    Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Medtronic, Inc.; Zoll Medical Corporation
    Received grants for clinical research from: Boston Scientific; Medtronic, Inc.; St. Jude Medical

    Dr. Varma does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Varma does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Alon Barsheshet, MD

    Adjunct Assistant Professor, University of Rochester, Rochester, New York; Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel

    Disclosures

    Disclosure: Alon Barsheshet, MD, has disclosed no relevant financial relationships.

    Dr. Barsheshet does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Barsheshet does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Valentina Kutyifa, MD, PhD

    Research Assistant Professor, University of Rochester, Rochester, New York

    Disclosures

    Disclosure: Default disclosure statement (modify if necessary): Valentina Kutyifa, MD, PhD, has disclosed the following relevant financial relationships:
    Served as a speaker or a member of a speakers bureau for: Boston Scientific; Zoll Medical Corporation
    Received grants for clinical research from: Boston Scientific; Zoll Medical Corporation

    Dr. Kutyifa does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Kutyifa does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

  • George Boutsalis, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: George Boutsalis has disclosed no relevant financial relationships.

CME Reviewer

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Addressing Patients at High Risk for SCA: Evaluating WEARIT-II

Authors: Niraj Varma, MD, PhD; Alon Barsheshet, MD; Valentina Kutyifa, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 6/13/2016

Valid for credit through: 6/13/2017

processing....

  • Print